• 6OS3Crystal structure of native CymD prenyltransferaseUpdated Aug 11, 2026
• 4RD7The crystal structure of a Cupin 2 conserved barrel domain protein from Salinispora arenicola CNS-205Updated Aug 10, 2026
• 4O0BIdentification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's diseaseUpdated Aug 10, 2026
• 4O09Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s diseaseUpdated Aug 10, 2026
• 4O07Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's diseaseUpdated Aug 10, 2026
• 4O05Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's diseaseUpdated Aug 10, 2026
• 4O04Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's diseaseUpdated Aug 10, 2026
• 4N00Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNSUpdated Aug 10, 2026
• 3OY1Highly Selective c-Jun N-Terminal Kinase (JNK) 2 and 3 Inhibitors with In Vitro CNS-like Pharmacokinetic PropertiesUpdated Aug 10, 2026